Literature DB >> 21784774

Trigger factors for familial hemiplegic migraine.

Jakob Møller Hansen1, Anne Werner Hauge, Messoud Ashina, Jes Olesen.   

Abstract

OBJECTIVE: The aim was to identify and describe migraine trigger factors in patients with familial hemiplegic migraine (FHM) from a population-based sample.
METHODS: 127 FHM patients were sent a questionnaire listing 16 trigger factors. Distinction was made between attacks of hemiplegic migraine (HM) and migraine with aura (MA) or without aura (MO) within each patient.
RESULTS: The response rate was 59% (75/127) of whom 57 (76%) had current HM attacks. Sixty-three per cent (47/75) reported at least one factor triggering HM, and 36% (27/75) reported at least one factor that often or always caused HM. Twenty per cent (15/75) reported only HM, whereas FHM in combinations with MA and MO were reported by 80% (60/75). Stress (with attacks either following or during the stress), bright light, intense emotional influences and sleeping too much or too little were the trigger factors mentioned by most.
CONCLUSION: Many FHM patients report trigger factors and one-third reported at least one trigger factor often or always triggering FHM. The typical triggers are the same as for MA. Patients should be educated to avoid these factors. The role of trigger factors in the onset of new or first attacks of FHM remains unknown.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21784774     DOI: 10.1177/0333102411415878

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  9 in total

Review 1.  Alcohol as a dietary trigger of primary headaches: what triggering site could be compatible?

Authors:  A Panconesi; M L Bartolozzi; S Mugnai; L Guidi
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Relief Following Chronic Stress Augments Spreading Depolarization Susceptibility in Familial Hemiplegic Migraine Mice.

Authors:  Mustafa Balkaya; Jessica L Seidel; Homa Sadeghian; Tao Qin; David Y Chung; Katharina Eikermann-Haerter; Arn M J M van den Maagdenberg; Michel D Ferrari; Cenk Ayata
Journal:  Neuroscience       Date:  2019-07-09       Impact factor: 3.590

Review 3.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

4.  Meningeal norepinephrine produces headache behaviors in rats via actions both on dural afferents and fibroblasts.

Authors:  Xiaomei Wei; Jin Yan; Dipti Tillu; Marina Asiedu; Nicole Weinstein; Ohannes Melemedjian; Theodore Price; Gregory Dussor
Journal:  Cephalalgia       Date:  2015-01-19       Impact factor: 6.292

5.  Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Authors:  Nadine Pelzer; Anine H Stam; Joost Haan; Michel D Ferrari; Gisela M Terwindt
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

6.  Familial Hemiplegic Migraine Type 3 (FHM3) With an SCN1A Mutation in a Chinese Family: A Case Report.

Authors:  Na Shao; Haining Zhang; Xue Wang; Wuqiong Zhang; Miaomiao Yu; Hongmei Meng
Journal:  Front Neurol       Date:  2018-11-15       Impact factor: 4.003

7.  Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine.

Authors:  Neven Maksemous; Claire D Blayney; Heidi G Sutherland; Robert A Smith; Rod A Lea; Kim Ngan Tran; Omar Ibrahim; Jeffrey R McArthur; Larisa M Haupt; M Zameel Cader; Rocio K Finol-Urdaneta; David J Adams; Lyn R Griffiths
Journal:  Front Mol Neurosci       Date:  2022-07-19       Impact factor: 6.261

Review 8.  Alcohol-induced headaches: Evidence for a central mechanism?

Authors:  Alessandro Panconesi
Journal:  J Neurosci Rural Pract       Date:  2016 Apr-Jun

9.  Responsivity to light in familial hemiplegic migraine type 1 mutant mice reveals frequency-dependent enhancement of visual network excitability.

Authors:  Matthijs J L Perenboom; Maarten Schenke; Michel D Ferrari; Gisela M Terwindt; Arn M J M van den Maagdenberg; Else A Tolner
Journal:  Eur J Neurosci       Date:  2020-11-26       Impact factor: 3.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.